Poland - Pharmaceutical products

Description

Doxorubicin hydrochloride in pegylated liposomes, 2 mg/ml concentrate, 10 ml vial 830 op. A complex of doxorubicin and citrate in liposomes which corresponds to 50 mg of chlorine. Doxorubicin, 2 sets of 3 vials of 86 op. Carboplatinum, injection solution, 10 mg/ml, op. 1 vial of 45 ml 1 440 op. 2. Carboplatinum, injection solution, 10 mg/ml, op. 1 vial of 15 ml 900 op. 3. Carboplatinum, injection solution, 10 mg/ml, op. 1 vial of 5 ml 560 op. 3. Cladribinum 10 mg/ml, solution for infusion, op. 1 vial of 10 ml 385 op. Acidum levofolinicum, solution for injection and infusion, 50 mg/ml, 1 vial of 9 ml 1 140 op.2. Acidum levofolinicum, solution for injection and infusion, 50 mg/ml, 1 vial of 4 ml 290 op. Dacarbazinum 100 mg, powder for solution for injection or infusion, op. 10 vials of 100 mg each Op. 2. Dacarbazinum 200 mg, powder for solution for injection or infusion, op. 10 vials of 200 mg each Op. 2. Ethioposide, concentrate for solution for infusion, 100 mg, 1 vial of 5 ml 740 op.2. Ethioposide, concentrate for solution for infusion, 400 mg, 1 vial of 20 ml 220 op. Fluorouracilum, injection solution, 50 ml/mg, op.1 vial of 100 ml, physical and chemical stability after aseptic intake up to 28 days 1 540 op.2. Fluorouracilum, injection solution, 50 ml/mg, op.1 vial of 20 ml, physical and chemical stability after aseptic intake up to 28 days 120 op.2. Epirubicini hydrochloride 2 mg/ml, concentrate for solution for infusion, 10 mg, op. 1 vial of 5 ml each, op. 2. Epirubicini hydrochloride 2 mg/ml, concentrate for solution for infusion, 50 mg, op. 1 vial of 25 ml 120 op. 2. Vinorelbinum, concentrate for solution for infusion, 10 mg/ml, op. 1 vial and 1 ml 120 op. 2. Vinorelbinum, concentrate for solution for infusion, 10 mg/ml, op. 1 vial and 5 ml 20 op. Fulvestrantum 250 mg/5 ml, r-r for injection, op. 2 amp-strzy. 5 ml + 2 needles of syst. Enclosure 350 op. Cytarabinum, r-rush powder for injection, 100 mg, op. 1 vial of powder +1 amp. from rozp. 1 400 op. 2. Cytarabinum, r-rush powder for injection, 500 mg, op. 1 vial of powder. Cytarabinum, powder for r-ru preparation for injection, 1 g, 1 vial of powder. 1,200 op. Cisplatinum, concentrate for r-ru preparation for infusion, 1 mg/ml, 1 vial and 10 ml 1 100 op.2. Cisplatinum, concentrate for r-ru preparation for infusion, 1 mg/ml, 1 vial and 50 ml 400 op. Topotecanum, concentrate for r-ru preparation for infusion, 1 mg/ml, 1 vial of 1 ml 160 op. Deferoxamini mesilas, powder to prepare. r-ru for 500 mg injection, op. 10 vials each. 240 op. IIdarubicinum 10 mg, r-ru preparation powder for injection, op. 1 vial 80 op. Idarubicinum 5 mg, r-ru preparation powder for injection, op. 1 vial 60 op. Mitoxantronum, concentrate for r-ru preparation for infusion, 2 mg/ml, op.1 vial 10 ml 130 op. Octreotidium 30 mg, powder and solvent for suspension for injection, op. 1 vial + 1 amp - syringe with 2 ml 30 op. Uromitexan 100 mg/ml, solution for injection, op. 15 amp. 4 ml 235 ml each op. 235 ml. Lanreotidium, solution for injection, 120 mg, op. 1 amp - syringe 0.5 ml each 85 op. Paclitaxelum 6 mg/ml, concentrate for r-ru preparation for infusion, op. 1 vial 5 ml 660 op. 2. Paclitaxelum 6 mg/ml, concentrate for r-ru preparation for infusion, op. 1 vial 16,7 ml 160 op. 3. Paclitaxelum 6 mg/ml, concentrate for r-ru preparation for infusion, op. 1 vial 50 ml 720 op. 3. Ifosfamdum 1 g powder for r-ru preparation for injection, op. 1 vial 60 op. 2. Ifosfamdum 2 g powder for r-ru preparation for injection, op. 1 vial 60 op. Docetaxelum 20 mg/ml concentrate for r-ru preparation for infusion, op. 1 vial 4 ml 560 op. 2. Docetaxelum 20 mg/ml concentrate for r-ru preparation for infusion, op. 1 vial 1 ml 460 op. Bendamustinum hydrochloridm, powder for preparing r-ru concentrate for infusion, op. 5 vials of 25 mg 125 op. 2. Bendamustinum hydrochloridm, powder for preparing r-ru concentrate for infusion, op. 5 vials of 100 mg 140 op. 3. Fludarabinum 25 mg/ml, concentrate for r-ru preparation for infusion injections, op. 1 vial 2 ml 190 op. Cyclophosphamide, powder for solution for injection 1 g, 1 vial of 75 ml 1 160 op. Cyclophosphamidum, powder for solution for injection 200 mg, op. 1 vial of 10 ml 2 320 op. Beta Epoetinum, r-r for injection, 30 000 IU, op. 1 amp. - syringe 130 op. Methotrexatum concentrate for r-ru preparation for infusion, 100 mg/ml, op. 1 vial, 50 ml each, 32 op. 2. Methotrexatum, solution for injection in a pre-filled syringe, 50 mg/ml, op. 12 amp.-sharp. After 0,5 ml 6 op. Methotrexatum inj. 50 mg/5 ml x 1 vial 140 op. Pixantroni dimaleas, powder for preparing solution concentrate for infusion, 29 mg, op. 1 vial 75 op. Mycophenolas mofetil, hard capsules, 250 mg, op. 100 capsules, 5 op. Mycophenolas mofetil, film-coated tablets, 500 mg, op. 50 tabl. 15 op. Ondansetronum, solution for injection or infusion, 2 mg/ml, op. 5 amp. 2 ml each 1 735 op. Ondansetronum, solution for injection or infusion, 2 mg/ml, op. 5 amp. 4 ml each 5 840 op. Filgrastimum, solution for injection or infusion, 30 million IU/0.5 ml, op. 1 amp. - strz. 3 540 op. Filgrastimum, solution for injection or infusion, 48 million IU/0.5 ml, op. 1 amp. - strz. 4 420 op. Mitomycinum, powder for solution for injection, 20 mg, op. 1 vial of 20 mg 100 op. Busulfanum, concentrate for solution for infusion 6 mg/ml, op. 1 vial 10 ml 300 op.

Opportunity closing date

26 September 2019

Value of contract

to be confirmed